The Relationship Between Leucine-Rich- α-2-Glycoprotein-1 Plasma Protein with Cervical Cancer
Keywords:
Cell differentiation, pathology, LRG1 protein, neoplasm staging, Uterine Cervical NeoplasmsAbstract
Introduction: Leucine-rich-α-2-glycoprotein-1 (LRG-1) has been identified as a significant role in the pathogenesis of disease development, including cancer, and serves as a prognostic marker for cancer. However, there has been no research on the use of LRG-1 as a marker for cervical cancer (CaCx). This study analyzes the relationship between plasma LRG-1 and the stage, histological type, and degree of differentiation of CaCx.
Methods: This cross-sectional study was conducted on patients diagnosed with CaCx who underwent examination at our institution. The results of the anatomical pathology examination, including stage, histological type, and degree of differentiation of CaCx, were recorded. Serum LRG-1 was measured using an ELISA kit. Statistical analysis used the Kruskal Wallis, Mann Whitney, and Fisher Exact tests.
Results: A total of 88 women diagnosed with CaCx were collected, consisting of 23 patients in the early stage and 65 patients in the advanced stage. There was a significant relationship between plasma LRG-1 levels and the stage of CaCx (p < 0.05). Advanced CaCx had a higher average plasma LRG-1 level than early stage. Histopathological type and differentiation grade were not significantly related to plasma LRG-1 levels (p > 0.05).
Conclusion: Plasma LRG-1 can be a biomarker in predicting the stage of CaCx
Downloads
Metrics
References
Hull R, Mbele M, Makhafola T, Hicks C, Wang S-M, Reis RM, et al. Cervical cancer in low and middle-income countries. Oncol Lett 2020;20:2058–74. doi: 10.3892/ol.2020.11754.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209–49. doi: 10.3322/caac.21660.
Prihantono, Reski Rusli, Robert Christeven, Muhammad Faruk. Cancer Incidence and Mortality in a Tertiary Hospital in Indonesia: An 18-Year Data Review. Ethiop J Health Sci 2023;33. doi: 10.4314/ejhs.v33i3.15.
The Global Cancer Observatory. Cancer Incidence in Indonesia. International Agency for Research on Cancer; 2022.
Wahidin M, Febrianti R, Susanty F. Burden of Cervical Cancer in Indonesia: Findings From the Global Burden of Disease Study 1990–2017. In: Proceedings of the 4th International Symposium on Health Research (ISHR 2019). Bali, Indonesia: Atlantis Press; 2020.
Xie L, Chu R, Wang K, Zhang X, Li J, Zhao Z, et al. Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach. Front Oncol 2020;10:1353. doi: 10.3389/fonc.2020.01353.
Wang J, Zheng H, Han Y, Wang G, Li Y. A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer. Int J Genomics 2020;2020:4535820. doi: 10.1155/2020/4535820.
Zhou H, Li Q, Wang T, Liang H, Wang Y, Duan Y, et al. Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics. Medicine (Baltimore) 2019;98:e16192. doi: 10.1097/MD.0000000000016192.
Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J. LRG1: an emerging player in disease pathogenesis. J Biomed Sci 2022;29:6. doi: 10.1186/s12929-022-00790-6.
Ma H, Lu F, Guo Y, Shen Z, Chen Y. The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury. Biomed Res Int 2021;2021:7365204. doi: 10.1155/2021/7365204.
Yang F-J, Hsieh C-Y, Shu K-H, Chen I-Y, Pan S-Y, Chuang Y-F, et al. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease. Sci Rep 2020;10:5988. doi: 10.1038/s41598-020-62989-7.
Agameia AE, Swelem RS, Sokkary HHE, Elsayed GS. Study of leucine-rich alpha-2-glycoprotein-1 marker serum level in cases of malignant epithelial ovarian tumors. Int J Reprod Contracept Obstet Gynecol 2020;10:12. doi: 10.18203/2320-1770.ijrcog20205747.
Sun D-C, Shi Y, Wang L-X, Lv Y, Han Q-L, Wang Z-K, et al. Leucine-rich alpha-2-glycoprotein-1, relevant with microvessel density, is an independent survival prognostic factor for stage III colorectal cancer patients: a retrospective analysis. Oncotarget 2017;8:66550–8. doi: 10.18632/oncotarget.16289.
Yamamoto M, Takahashi T, Serada S, Sugase T, Tanaka K, Miyazaki Y, et al. Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer. Cancer Sci 2017;108:2052–60. doi: 10.1111/cas.13329.
Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Weeraphan C, Keeratichamroen S, Sritana N, et al. Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. Oncol Lett 2019;17:5453–68. doi: 10.3892/ol.2019.10227.
Astari P, Rauf S, Jusuf EC, Chalid StMT, Arifuddin S, Farid RB. Correlation of Leucine-Rich-α-2-Glycoprotein- 1 (LRG-1) Level in Urine with Cervical Cancer Stage, Histology Type and Histology Grading. Obgynia 2023;6:203. doi: 10.24198/obgynia.v6i2.489.
Mohammed FA, Tune KK, Jett M, Muhie S. Cervical Cancer Stages, Human Papillomavirus Integration, and Malignant Genetic Mutations: Integrative Analysis of Datasets from Four Different Cohorts. Cancers (Basel) 2023;15:5595. doi: 10.3390/cancers15235595.
Wipperman J, Neil T, Williams T. Cervical Cancer: Evaluation and Management. Am Fam Physician 2018;97:449–54.
Pratiwi SE, Trianto HF, Fatinah NN, Ilmiawan MI, Fitrianingrum I, Lestari D. The Profile of Cervical Cancer Patients at Soedarso Hospital. Indonesian Journal of Cancer 2022;16:33. doi: 10.33371/ijoc.v16i1.845.
Noguchi T, Zaitsu M, Oki I, Haruyama Y, Nishida K, Uchiyama K, et al. Recent Increasing Incidence of Early-Stage Cervical Cancers of the Squamous Cell Carcinoma Subtype among Young Women. Int J Environ Res Public Health 2020;17:7401. doi: 10.3390/ijerph17207401.
Tekalegn Y, Sahiledengle B, Woldeyohannes D, Atlaw D, Degno S, Desta F, et al. High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies. Womens Health (Lond) 2022;18:17455065221075904. doi: 10.1177/17455065221075904.
Kashyap N, Krishnan N, Kaur S, Ghai S. Risk Factors of Cervical Cancer: A Case-Control Study. Asia Pac J Oncol Nurs 2019;6:308–14. doi: 10.4103/apjon.apjon_73_18.
Faizah R, Putranto RA, Sudarsono S, Wening S, Sukma D, Budiani A. Genes expression analysis of EgUnk1, EgZFP2, and EgIPK2b in oil palm using Ct value correction and two relative quantification approaches. Indones J Biotechnol 2024;29:129. doi: 10.22146/ijbiotech.71816.
Sulistyawati D, Faizah Z, Kurniawati EM. An Association Study of Cervical Cancer Correlated with The Age of Coitarche in Dr. Soetomo Hospital Surabaya. Indonesian Journal of Cancer 2020;14:3. doi: 10.33371/ijoc.v14i1.639.
Mekonnen AG, Mittiku YM. Early-onset of sexual activity as a potential risk of cervical cancer in Africa: A review of literature. PLOS Glob Public Health 2023;3:e0000941. doi: 10.1371/journal.pgph.0000941.
Popova A, Vasiļvolfa A, Rācenis K, Erts R, Šlisere B, Saulīte AJ, et al. Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients. Ann Transplant 2022;27:e936751. doi: 10.12659/AOT.936751.
Kakar M, Berezovska MM, Broks R, Asare L, Delorme M, Crouzen E, et al. Serum and Urine Biomarker Leucine-Rich Alpha-2 Glycoprotein 1 Differentiates Pediatric Acute Complicated and Uncomplicated Appendicitis. Diagnostics (Basel) 2021;11:860. doi: 10.3390/diagnostics11050860.
Rui T, Ling DZ, Jing M. The Expression of LRG1 in Cervical Squamous Carcinoma and Its Relationship with Microvessel Density. Journal of Kunming Medical University 39:44–51.
Hoefsmit EP, Völlmy F, Rozeman EA, Reijers ILM, Versluis JM, Hoekman L, et al. Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer Res Commun 2023;3:672–83. doi: 10.1158/2767-9764.CRC-23-0015.
Dritsoula A, Camilli C, Moss SE, Greenwood J. The disruptive role of LRG1 on the vasculature and perivascular microenvironment. Front Cardiovasc Med 2024;11:1386177. doi: 10.3389/fcvm.2024.1386177.
Xie Z-B, Zhang Y-F, Jin C, Mao Y-S, Fu D-L. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling. J Exp Clin Cancer Res 2019;38:75. doi: 10.1186/s13046-019-1088-0.
.
..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
